INCENP / Inner centromere protein · Western blot design guide

Design a Western Blot for INCENP

Real validated INCENP Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-INCENP WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for INCENP: expected band ~105.4 kDa, hero antibody A02466, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable INCENP Western blot protocol sheet — expected band ~105.4 kDa, antibody A02466, controls and PMC citations. Open the full INCENP WB guide →

INCENP Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~105.4 kDa
Gel 8–10% (standard starting point)
Positive control ⓘ Appendix (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Phosphorylated
Caveat Phosphorylation-state controls
Gene-set association MSigDB Hallmark membership
Isoform 2 isoform(s)
Section 1

Real Curated INCENP Western Blot Protocols

The A02466 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateHEK293T, sp2/0, PC12 (catalog A02466)
Gel %8–10% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferWet/tank transfer; optimize duration (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA02466; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected INCENP Western Blot Band Size?

INCENP is predicted at 105.4 kDa; isoforms and phosphorylation could affect migration, but no empirical band or visible shift is established.

What am I looking at on my blot?
Band near 105.4 kDaConsistent with the predicted INCENP size; confirm identity with controls
Single band away from 105.4 kDaAn alternative isoform is possible, but its migration is unknown
Two bands at different positionsIsoforms 1 and 2 are possible contributors; distinct migration is unverified
Closely spaced bandsDifferent phosphorylation states are possible; a visible shift is unverified
💡Expected INCENP appearanceUniProt predicts INCENP at 105.4 kDa, but no empirical band size is supplied; confirm a candidate band with INCENP knockdown or another band-identity control.
How each factor affects band size
UniProt predicted massPlaces the reference size at 105.4 kDa
Isoform 1Has no supplied isoform-specific mass or migration
Isoform 2Has no supplied isoform-specific mass or migration
Alternative splicing of isoforms 1 and 2Could change band size, but distinct bands are not established
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateINCENP localizes to the nucleus, centromere, spindle and midbodyCheck extraction and compare relevant cell fractions
Band higher than expectedPhosphorylation may affect mobility, but a shift is unverifiedCompare phosphatase-treated material and confirm band identity
Band lower than expectedIsoform migration is unknownCheck isoform expression and confirm band identity by INCENP knockdown
Multiple bandsIsoforms or phosphorylation states are possible contributorsUse INCENP knockdown and compare phosphatase-treated material
Weak or no signalRecovery may vary with INCENP's subcellular distributionCheck extraction and enrich the relevant fraction

Sample controls for INCENP Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for INCENP in Western blot, you can use appendix tissue, which HPA scores High.
Positive control: Appendix (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: INCENP is intracellular, and HPA identifies adipose tissue as a not-detected negative comparator.

HPA tissue expression evidence for INCENP

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Appendix endocrine cells High Protein (IHC) HPA →
Colon endocrine cells High Protein (IHC) HPA →
Duodenum endocrine cells High Protein (IHC) HPA →
Lymph node germinal center cells High Protein (IHC) HPA →
Rectum endocrine cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Bronchus respiratory epithelial cells Not detected Protein (IHC) HPA →
Cerebellum cells in granular layer Not detected Protein (IHC) HPA →
Cerebral cortex endothelial cells Not detected Protein (IHC) HPA →
Epididymis glandular cells Not detected Protein (IHC) HPA →
Section 3

Advanced INCENP Western Blot Tips

Deeper troubleshooting and optimisation questions for INCENP, answered from its protein features.

Where should the INCENP band appear relative to its predicted mass?
Band shift · The canonical sequence has a predicted mass of 105.4 kDa. No observed band position is supplied, so use 105.4 kDa as a reference rather than an expected apparent mass. The listed features alone cannot establish a visible shift or explain a difference from the prediction.
Could INCENP isoforms produce separate bands?
Isoforms · UniProt lists isoforms 1 and 2. Isoform 2 lacks residues 532–535 of the canonical sequence. Check which isoform an antibody can recognize, but do not assign separate bands from this four-residue difference without supporting evidence.
Which phosphorylation sites matter when choosing a phospho-specific antibody?
PTM · UniProt lists 37 modified residues, including Thr892, Ser893 and Ser894 phosphorylated by AURKB and AURKC. Match the antibody’s target site to the listed UniProt coordinate; paper or antibody numbering may use a different convention. A site annotation does not establish how strongly a band will appear.

INCENP has numerous listed phosphoserine and phosphothreonine sites, including Thr892, Ser893 and Ser894. These features support considering phosphorylation when examining band patterns, but they do not demonstrate a visible shift. Compare matched samples and confirm any proposed phosphorylation-dependent pattern experimentally.
Does this guide establish induction of INCENP?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for INCENP?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02466 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How can INCENP bands be quantified across samples?
Quantitation · Define the band being measured consistently across samples, and document whether the antibody detects total INCENP or a listed phosphorylation site. Because two isoforms and many phosphorylation sites are annotated, a phospho-specific signal should not automatically be treated as total INCENP abundance.
How should cell-cycle context affect INCENP comparisons?
Interpretation · INCENP is annotated for the cell cycle and mitosis and localizes to centromeres, the spindle and the midbody. Record and match the cell-cycle context when comparing samples. The supplied features do not specify an induction condition or predict a change in total INCENP abundance.

Check the band against the 105.4 kDa canonical prediction, the four-residue deletion in isoform 2 and the listed phosphorylation sites. None of these features alone identifies an unexpected band or proves a mass shift. Verify band identity before labeling additional bands as an isoform or modified INCENP.
Boster reagents

INCENP Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot (WB) analysis of INCENP polyclonal antibody at 1:500 dilution Lane1:HEK293T cell lysate Lane2:sp2/0 cell lysate Lane3:PC12 cell lysate
Anti-Inner centromere protein INCENP Antibody
Cat # A02466

A02466 is an anti-INCENP antibody listed for human, mouse, and rat. Its Western blot image uses HEK293T, sp2/0, and PC12 cell lysates at 1:500 dilution. No publication evidence is supplied.

Which to pick: A02466 is the only listed option. It has a Western blot image with three named cell lysates; use the reported samples and 1:500 dilution as the practical starting point.

Source: BosterBio INCENP gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.